MedTrace Logo

ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry

NCT00264069 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2622

Last updated 2011-05-19

No results posted yet for this study

Summary

The purpose of this study is to find out how well new treatment plans are followed by outpatients with major mental illnesses (schizophrenia, bipolar disorder, depression, personality disorder) and to determine the relationship between a diagnosis of schizophrenia and compliance with a treatment plan.

Conditions

Interventions

DRUG

antipsychotic

as prescribed

DRUG

antidepressants

as prescribed

Sponsors & Collaborators

  • Janssen-Cilag, S.A.

    lead INDUSTRY

Principal Investigators

  • Janssen-Cilag S.A. (formerly Janssen Sp) Clinical Trial · Janssen-Cilag, S.A.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2006-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00264069 on ClinicalTrials.gov